Biobanking For Medicine Market Size Current and Future Industry Trends, 2018 – 2026

Market Scenario

Global Biobanking for Medicine Market was valued US$ 1.86 Bn in 2017 and is estimated to attain US$ 3.69 Bn by 2026 at a CAGR of 8.94%.

Global Biobanking for Medicine Market

Biobanking for drugs market is segmented into the product, pattern kind, software, and area. Based on product, biobanking for drugs market is classed into gear, consumables, companies, and software program. Equipment is holding the highest market due to growing the variety of biobanks and biospecimens.

Get Access to pattern pages @

Increasing the demand for customized drugs, genomics research & analysis of illnesses, and a rising development of conversing wire blood stem cells of new-borns these elements act as drives to the biobanking for drugs market. Government & Private sector funding to assist analysis for cost-effective medicines.

North America holds the largest share of biobanking for drugs market due to elevating the variety of biobanks, analysis of medicines, cells, and remedy. North America adopted by Europe, Asia Pacific, Latin America, and Middle East & Africa.

Key participant’s research, analyzed, profiled and benchmarked in biobanking for drugs market are Tecan Group Ltd., Thermo Fisher Scientific Inc., Qiagen N.V., Hamilton Company, Brooks Automation, TTP Labtech, VWR Corporation, Promega Corporation, Worthington Industries, Chart Industries, Becton, Dickinson and Company, Merck KGaA, Micronic, LVL Technologies GmbH & Co. KG, Panasonic Healthcare Holdings Co. Ltd, Greiner Bio One, Biokryo GmbH, Biobank AS, Biorep Technologies Inc., Cell & Co Bioservices, RUCDR inifinite biologics, Modul-Bio, CSols Ltd, Ziath, AIS, AKH Biobank, AllCells, Allied Minds, Cellectics, China Stems Cells, CordLife, Cryo Save, Covance, CORE Informatics and LabVantage Solutions Inc.
Scope of Global Biobanking for Medicine Market:

Global Biobanking for Medicine Market, by Product:

• Equipment
• Consumables
• Services
• Software
Global Biobanking for Medicine Market, by Sample Type:

• Blood merchandise
• Human tissues
• Cell traces
• Nucleic acids
Global Biobanking for Medicine Market, by Application:

• Life science
• Clinical analysis
• Regeneration drugs
Global Biobanking for Medicine Market, by Region:

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
Key Players in Global Biobanking for Medicine Market:

• Tecan Group Ltd.
• Thermo Fisher Scientific Inc.
• Qiagen N.V.
• Hamilton Company
• Brooks Automation
• TTP Labtech
• VWR Corporation
• Promega Corporation
• Worthington Industries
• Chart Industries
• Becton
• Dickinson and Company
• Merck KGaA
• Micronic
• LVL Technologies GmbH & Co. KG
• Panasonic Healthcare Holdings Co. Ltd
• Greiner Bio One
• Biokryo GmbH
• Biobank AS
• Biorep Technologies Inc.
• Cell & Co Bioservices
• RUCDR inifinite biologics
• Modul-Bio
• CSols Ltd
• Ziath
• AKH Biobank
• AllCells
• Allied Minds
• Cellectics
• China Stems Cells
• CordLife, Cryo Save
• Covance
• CORE Informatics
• LabVantage Solutions Inc.